Greenland Capital Management LP Pliant Therapeutics, Inc. Transaction History
Greenland Capital Management LP
- $626 Billion
- Q4 2024
A detailed history of Greenland Capital Management LP transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Greenland Capital Management LP holds 30,000 shares of PLRX stock, worth $44,100. This represents 0.05% of its overall portfolio holdings.
Number of Shares
30,000Holding current value
$44,100% of portfolio
0.05%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding PLRX
# of Institutions
175Shares Held
64.8MCall Options Held
228KPut Options Held
772K-
Deep Track Capital, LP Greenwich, CT5.97MShares$8.78 Million3.46% of portfolio
-
Black Rock Inc. New York, NY4.97MShares$7.31 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.63MShares$6.81 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.23MShares$4.75 Million0.0% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY3.2MShares$4.7 Million1.61% of portfolio
About PLIANT THERAPEUTICS, INC.
- Ticker PLRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,682,000
- Market Cap $71.6M
- Description
- Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...